Neurosynaptic Communications
Democratizing affordable, quality, and remote healthcare delivery
Founded in 2002 by Sameer Sawarkar and Rajeev Kumar, Neurosynaptic Communications aims to eliminate health complications faced by the developing world. The Bengaluru-based company is backed by venture capital investors, Healthquad, Indian Angel Network (IAN), Axilor Ventures, and e-Zest Solutions Ltd.
The remote healthcare delivery solutions provider is committed to make quality healthcare affordable to masses, through its telemedicine and Managed Healthcare Services. This is made possible through its cloud-based telemedicine platform ReMeDi® that provides screening, primary diagnosis, and triaging capabilities by linking various healthcare ecosystem components (doctors, patients, health workers, diagnostics, medicines, etc.). The ReMeDi® solution captures processes and entities making affordable and quality healthcare delivery possible on the ground.
Neurosynaptic’s award-winning solutions are easy to use and enable end-to-end health care delivery, even in difficult-to-access and resource constrained areas. These world-class solutions are manufactured with globally accepted highest quality processes, validated and accepted by the medical fraternity.
Neurosynaptic’s Flagship Platform ReMeDi® (Acronym for Remote Medical Diagnostics) is a comprehensive Solution for Telemedicine/ Teleconsultations, and Managed Healthcare Services. ReMeDi® Solution comprises the Software Platform and a wide range of point-of-care medical devices.
Neurosynaptic has indigenously designed and manufactured several medical devices, including the Infrared Thermometer, Pulse Oximeter, Blood Pressure Monitor, Digital Stethoscope, ECG Machine, etc. All these devices are portable, lightweight, and wireless devices that easily connect with Smartphones/ tablets/ Laptops via Bluetooth-Low-Energy (BLE) Technology. These devices are seamlessly integrated with the Software platform and facilitate errorless medical data exchange.
ReMeDi® Software Platform has various modules for capturing the complete OPD Workflow including appointment booking, Diagnostic measurements, prescription generation, billing, Electronic Medical Records, etc. It is user-friendly and offers high configurability and role-based access for administrators, managers, doctors, patients, etc.
The ReMeDi® Platform is built for Managed Healthcare Services, and has enabled 2600 Telemedicine centres, providing consultations to over a million people.
ReMeDi™ has emerged as a vital channel of health care delivery in poor, rural pockets of developing countries delivering care close to clients and saving precious resources.
Neurosynaptic undertakes Managed Healthcare Services including project implementation and management at private as well as Government facilities through Private-Public-Partnership (PPP Models) and along with several SI Partners, Implementation Partners, Hospital Partners, and Foundations
Data shows that over 80% of ReMeDi® telemedicine clients are from the poor economic quintiles, with more than 50% representing the poorest quintile, despite a fee-for-service model. Quality healthcare reaches to the patients within a distance which is less than that to a government PHC in most cases.
Neurosynaptic Communications has created a tool kit that can be used to provide end-to-end Healthcare Service Delivery through health workers to administer 35 different tests in an identity-secure manner, and enable doctors to provide services remotely. If a city hospital has a catchment area of 50 villages around it, it doesn’t have to depute doctors or nurses to conduct the tests, and provide healthcare access. Patients don’t have to travel to the hospital to get these tests done.
The company has touched 50 Million + lives through 2600+ centres in over 12 countries including 12+ states in India. A partnership-based approach is taken for improving and expanding the reach.
To cater to the needs that arose with COVID-19 Pandemic, we have bundled our offerings into several different models, like the Direct-to-home teleconsultation model. This enables the Doctors at any hospital to connect with their patients who can use the application on their smartphones and tele-consult from the comfort of their homes. This has received an excellent response from the users.
Having achieved over a 110% revenue growth in the previous financial year with 68% more customer acquisitions, the Company has significant contracts at hand with a forecast of 260% revenue growth in the current financial year. This year is going to be an extremely busy and important year for the Company like the previous year. With increased acceptance for the Managed Healthcare Services, and strong partnerships in multiple geographies, the Company is looking at large growth in both domestic and overseas business, and intends to make investments into appropriate Teams, Delivery and Product Development for local regulatory requirements.
We believe that Neurosynaptic Communications is trying to solve a real need to access quality healthcare at affordable costs by connecting patients in underserved areas to doctors at the hub through their video consultation platform which is able to operate at low bandwidths. Through its innovative ‘Clinic in a Suitcase’ offering with more than 30 point of care tests and its proprietary blue-tooth enabled hardware devices, it offers a cloud-based platform for collection and storage of clinical data and facilitation of a comprehensive tele consult. Each consultation costs less than USD 2 and also provides other cost savings (travel and lost wages) to the tune of USD 15. HealthQuad, an Indian transformative healthcare fund, seeks to invest in disruptive, technology based and innovation driven businesses like Neurosynaptic Communications, which can transform healthcare in India and other low- and middle-income countries with similar healthcare challenges.
- Pinak Shrikhande, Director, HealthQuad